ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Organ Systems Working Group Chairs Ask for Set-Aside Funds

December 6, 1985

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998

M.D. Anderson, Madrid In Joint Program

September 2, 1988